Your basket is currently empty!
» Kidney Cancer News » Novel Prognostic Markers in Renal Cancer
Novel Prognostic Markers in Renal Cancer
Royal Marsden NHS Foundation Trust is working on the profiling of the expression of signal transduction biomarkers, gene expression, gene copy numbers and effect of mutations of the VHL gene in renal cancer and their relationship to clinical outcomes. For more information please click here.
Kidney Cancer UK
Kidney Cancer UK is the UK’s leading kidney cancer charity. We seek to reduce the harm caused by kidney cancer by increasing knowledge and awareness, providing patient information and by supporting research into the causes, prevention and treatment of the disease